Actinium Pharmaceuticals, Inc.
ATNM
$1.52
-$0.03-1.94%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M |
| Total Depreciation and Amortization | 205.00K | 204.00K | 202.00K | 189.00K | 216.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.87M | 1.20M | 1.34M | 1.37M | 1.38M |
| Change in Net Operating Assets | -715.00K | -506.00K | -1.95M | 1.82M | -298.00K |
| Cash from Operations | -7.57M | -5.75M | -11.98M | -7.97M | -7.37M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -11.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -2.00K | -2.00K | -3.00K | -2.00K |
| Issuance of Common Stock | -- | -- | 4.60M | 9.96M | 14.77M |
| Repurchase of Common Stock | -- | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.00K | -3.00K | 4.60M | 9.95M | 14.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.58M | -5.75M | -7.37M | 1.98M | 7.38M |